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Acute kidney injury (AKI) is a syndrome of renal dysfunction resulting in sudden onset decline in glomerular filtration rates (GFRs) and inability of kidneys to regulate acid, 
electrolyte, and fluid balance [1]. Kidney functions in neonates are 
unique as their GFR may vary depending on the degree of renal 
development at birth [2]. The predominant risk factors for impaired 
renal function in neonates are low gestational age, low birth 
weight, postnatal administration of vasopressors, indomethacin 
and antibiotics, postnatal illness, and use of positive pressure 
ventilation [3]. Various reviews of neonatal AKI among neonatal 
intensive care unit (NICU) patients report an incidence of 8–40%, 
depending on the definition used [4,5]. Mortality in neonates with 
AKI is as high as 60% [6]. Since majority of the studies related to 
the neonatal AKI are from the developed countries, we aimed to 
know the incidence rate of AKI and its associated risk factors among 
the NICU patients to depict the disease burden and its impact.
MATERIALS AND METHODS
This retrospective study was based on the data analysis of the 
records of the discharged and deceased patients, hospitalized in 
NICU from June 1, 2013, to May 31, 2014, in our tertiary care center 
catering the whole pediatric population of the Kashmir valley. 
The study was approved by the research and ethics committee 
of the institution. Newborns, who had known congenital kidney 
disease or if they did not survive beyond the first 48 h of life or 
who had a hospital stay for <24 h, were excluded from the study.
The following information was collected for data analysis: 
Age, gender, weight, provisional diagnosis, and treatment 
given including nephrotoxic drugs, important underlying 
metabolic/chronic condition(s), diagnoses, and serum creatinine 
(SCr) concentrations. The creatinine level was measured using 
the Jaffe method [7], and the GFR was determined using the 
updated Schwartz formula {height in cm × K/creatinine (mg/dL), 
where K = 0.413} [8]. Urine output criterion was not used for 
defining or staging AKI in our study.
Neonatal AKI was defined using the kidney disease: Improving 
global outcomes AKI definition, with one modification. Here, 
Stage 1 was defined as an increase of SCr ≥0.3 mg/dl or an 
increase in SCr by ≥50% within the 7 days of life, Stage 2 was 
defined as a doubling of SCr, and Stage 3 was defined as tripling 
of SCr [9]. We did not include urine output criteria because it 
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is often difficult to measure urine output in babies, and many 
premature infants with AKI are non-oliguric due to poor tubular 
function. Neonatal sepsis is defined as the presence of positive 
bacterial cultures in blood, cerebrospinal fluid, and/or urine 
associated with systemic clinical signs of infection such as fever, 
temperature instability, irritability, poor feeding, and respiratory 
distress [10].
RESULTS
Records of 1439 patients were analyzed, including 64.9% of 
male and 35.1% of female neonates. In our study, the incidence 
of AKI was 8.3% with a mortality rate of 34.1% among AKI 
neonates. Comprehensive result details of the study are given in 
Tables 1 and 2.
DISCUSSION
Various studies around the world have estimated that neonatal 
AKI affects 18–70% of the critically ill neonates and is 
associated with high mortality [11-13]. Neonates admitted to the 
NICU have prolonged hospital stay and are exposed to various 
drugs, interventions, and environment which influence the 
kidney development and the risk for the development of AKI. 
From our study, the overall incidence of AKI was 8.3%, which 
is similar to earlier studies [4,5]. However, the incidence rate 
in our study is lower than the other studies [11-13], which can 
be explained from the fact that we did not use highly sensitive 
urine and blood markers, and our study population was less 
critically ill.
The incidence by gestational age category showed the highest 
rates in the full term (>37 weeks) and lower rates in preterm (28–
36 weeks) neonates. AKI rate in term neonates (>37 weeks or 
older) was 60% which is consistent with those in other studies 
of term infants [14,15]. Lower incidence (40%) in the age group 
born at ≥29 weeks, could possibly be that these infants are not as 
critically ill as those of the <29 weeks and those of >37 weeks of 
gestational age groups. However, it has been observed in various 
studies that extreme premature born infants have the highest risk 
for developing the AKI as these are more often outborn, had 
lower Apgar scores, and had higher rates of respiratory failure, 
sepsis evaluation, hypoxic-ischemic encephalopathy, necrotizing 
enterocolitis, and maternal vaginal bleeding.
The AKI surveillance area with the lowest number of SCr 
checks had low AKI incidence, whereas the area with more 
often, SCr checks had higher AKI incidence rates. These findings 
suggest that the incidence of neonatal AKI would have been 
even higher if more rigorous AKI surveillance protocols were 
implemented. The most common cause for neonatal admission 
in our NICU was perinatal asphyxia followed by neonatal sepsis. 
It was observed that 7.9% of asphyxiated neonates and 10.2% 
of septic neonates had AKI, implying that septic neonates were 
the most frequently involved group for the development of AKI 
which is similar to other studies [4,16].
Our study shows a mortality rate of 34.1% (41/120) among 
the AKI affected neonates which is similar to the study conducted 
by Koralkar et al. [17]. However, it is higher than the more recent 
study [18], where mortality rate was 10% in AKI neonates, 
which could possibly be due to very robust system in detecting 
and treating the neonatal AKI in their setting. AKI mortality in 
our study was lower than the AKI mortality in septic neonates 
which was 70.2% [19] which could possibly be due to the higher 
number of critically sick neonates, delayed referral, and exposure 
to nephrotoxic drugs.
Adding to the limitation of this study was the fact that the data 
analysis of our study is retrospective; hence, the parameters we 
assessed were performed as part of clinical care when available 
and so the true incidence may be even higher. Second, our findings 
are limited by our definition of AKI, which relies on SCr changes 
to diagnose AKI in addition to the fact that we did not take urine 
output as a marker of AKI.
Table 1: Demographic profile and AKI of the studied neonates
Profile Total, 
n (%)
AKI present, 
n (%)
Gender
Males 933 (64.9) 78 (65)
Females 506 (35.1) 42 (35)
Gestational age
Term 1036 (72.2) 72 (60)
Preterm 403 (27.9) 48 (40)
Birth weight (g)
1000–1500 225 (15.6) 24 (20)
1501–2499 165 (11.5) 34 (28.3)
≥2500 1049 (72.2) 62 (51.7)
Total 1439 (100) 120 (100)
Table 2: Disease patterns, AKI, and mortality
Diagnosis Number AKI (%) Deaths (%)
Perinatal asphyxia 620 149 (7.9) 34
Stage I 338 6 (1.7) 0
Stage II 192 12 (6.2) 1 (8.3)
Stage III 90 31 (33.6) 16 (51)
Sepsis (including pneumonia, 
meningitis, and septic arthritis)
469 48 (10.2) 19 (39)
Neonatal hyperbilirubinemia 
(total bilirubin>15 mg/dL)
291 8 (2.7) 1 (12.5)
Hyaline membrane disease 30 2 (6.6) 1 (50)
Infant of diabetic mothers with 
hypoglycemia
10 1 (10) 0
Congenital heart disease with 
congestive cardiac failure
9 1 (11) 1 (100)
Necrotizing enterocolitis 6 3 (50) 1 (33.3)
Inborn errors of metabolism 
(prolonged hypoglycemia, 
neonatal cholestasis, 
seizures, etc.)
2 1 (50) 1 (100)
Anatomical/congenital KUB 
malformations
2 1 (50) 0
Total 1439 120 41
AKI: Acute kidney injury
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CONCLUSION
AKI is common in NICU patients and carries a high mortality 
risk. Most infants who developed AKI were suffering from 
varied neonatal insults and developed AKI within the 1st week 
of life. Heightened awareness and concrete efforts can prevent 
and ameliorate the impact of neonatal AKI in this vulnerable 
population.
REFERENCES
1. Andreoli S. Clinical evaluation and management. In: Avner E, Harmon W, 
Niaudet P, editors. Pediatric Nephrology. Philadelphia, PA: Lippincott Williams 
and Wilkins; 2004. p. 1233-352.
2. Haycock GB. Development of glomerular filtration and tubular sodium 
reabsorption in the human fetus and newborn. Br J Urol 1998;81 Suppl 2:33-8.
3. Walker MW, Clark RH, Spitzer AR. Elevation in plasma creatinine and 
renal failure in premature neonates without major anomalies: Terminology, 
occurrence and factors associated with increased risk. J Perinatol 
2011;31:199-205.
4. Selewski DT, Charlton JR, Jetton JG, Guillet R, Mhanna MJ, Askenazi DJ, 
et al. Neonatal acute kidney injury. Pediatrics 2015;136:e463-73.
5. Agras PI, Tarcan A, Baskin E, Cengiz N, Gürakan B, Saatci U, et al. Acute 
renal failure in the neonatal period. Ren Fail 2004;26:305-9.
6. Nada A, Bonachea EM, Askenazi DJ. Acute kidney injury in the fetus and 
neonate. Semin Fetal Neonatal Med 2017;22:90-7.
7. Leehey DJ, Braun BI, Tholl DA, Chung LS, Gross CA, Roback JA, et al. 
Can pharmacokinetic dosing decrease nephrotoxicity associated with 
aminoglycoside therapy. J Am Soc Nephrol 1993;4:81-90.
8. Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, 
et al. New equations to estimate GFR in children with CKD. J Am Soc 
Nephrol 2009;20:629-37.
9. Kellum JA, Lameire N, KDIGO AKI Guideline Work Group. Diagnosis, 
evaluation, and management of acute kidney injury: A KDIGO summary 
(Part 1). Crit Care 2013;17:204.
10. Trotman H, Bell Y, Thame M, Nicholson AM, Barton M. Predictors of poor 
outcome in neonates with bacterial sepsis admitted to the university hospital 
of the West Indies. West Indian Med J 2006;55:80-4.
11. Sarkar S, Askenazi DJ, Jordan BK, Bhagat I, Bapuraj JR, Dechert RE, 
et al. Relationship between acute kidney injury and brain MRI findings 
in asphyxiated newborns after therapeutic hypothermia. Pediatr Res 
2014;75:431-5.
12. Selewski DT, Jordan BK, Askenazi DJ, Dechert RE, Sarkar S. Acute kidney 
injury in asphyxiated newborns treated with therapeutic hypothermia. 
J Pediatr 2013;162:725-90.
13. Carmody JB, Swanson JR, Rhone ET, Charlton JR. Recognition and 
reporting of AKI in very low birth weight infants. Clin J Am Soc Nephrol 
2014;9:2036-43.
14. Alaro D, Bashir A, Musoke R, Wanaiana L. Prevalence and outcomes of 
acute kidney injury in term neonates with perinatal asphyxia. Afr Health Sci 
2014;14:682-8.
15. Askenazi DJ, Koralkar R, Hundley HE, Montesanti A, Patil N, 
Ambalavanan N, et al. Fluid overload and mortality are associated with 
acute kidney injury in sick near-term/term neonate. Pediatr Nephrol 
2013;28:661-6.
16. Bolat F, Comert S, Bolat G, Kucuk O, Can E, Bulbul A, et al. Acute kidney 
injury in a single neonatal intensive care unit in turkey. World J Pediatr 
2013;9:323-9.
17. Koralkar R, Ambalavanan N, Levitan EB, McGwin G, Goldstein S, 
Askenazi D, et al. Acute kidney injury reduces survival in very low birth 
weight infants. Pediatr Res 2011;69:354-8.
18. Charlton JR, Boohaker L, Askenazi D, Brophy PD, Angio DC, Fuloria M, 
et al. Incidence and risk factors of early onset neonatal AKI. Clin J Am Soc 
Nephrol 2019;14. Doi: 10.2215/CJN.03670318.
19. Mathur NB, Agarwal HS, Maria A. Acute renal failure in neonatal sepsis. 
Indian J Pediatr 2006;73:499-502.
Funding: None; Conflict of Interest: None Stated.
How to cite this article: Ashraf M, Bhat FA, Tak SA, Iqbal J, Kambay AH, 
Riyaz A. Neonatal acute kidney injury in a tertiary care hospital in Kashmir, 
Jammu and Kashmir, India. Indian J Child Health. 2019; 6(3):126-128.
Doi: 10.32677/IJCH.2019.v06.i03.007
